Kenvue (HAM:J4D) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


HAM:J4D Kenvue Inc HAM:J4D
70 GF Score
Price €16.52
GF Value €17.74
! 6 Warning Signs
View Full Analysis

What is Kenvue Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Kenvue's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


HAM:J4D vs KMB, EL, CHD: Margin of Safety % (DCF Earnings Based) Comparison

For the Household & Personal Products subindustry, Kenvue's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kenvue Margin of Safety % (DCF Earnings Based) vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kenvue's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Kenvue's Margin of Safety % (DCF Earnings Based) falls into.


HAM:J4D
70GF Score
Kenvue Inc HAM:J4D
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kenvue (HAM:J4D) Overvalued in 2026?

Based on GuruFocus' analysis, Kenvue stock appears to be undervalued. The current stock price of €16.52 is trading 6.9% below its estimated GF Value™ of €17.74.

Key valuation signals for HAM:J4D:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €17.74 vs. price of €16.52 (6.9% below fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the HAM:J4D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kenvue Business Description

Address 1 Kenvue Way, Summit, NJ, USA, 07901
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
70GF Score

Get the complete analysis for HAM:J4D

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.52
Price
€17.74
GF Value